Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Appco Pharma has filed 30 Abbreviated New Drug Applications (ANDAs) with 10 approvals including one tentative approval. The company specializes in complex dosage forms such as tablets, capsules, extended-release formulations, oral liquids and suspensions, and topical formulations. It operates two US FDA-approved manufacturing facilities in New Jersey.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Appco Pharma.